株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

細胞治療技術の世界市場の予測 〜2023年:消耗品・機器・ソフトウェア

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023

発行 MarketsandMarkets 商品コード 760888
出版日 ページ情報 英文 117 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
細胞治療技術の世界市場の予測 〜2023年:消耗品・機器・ソフトウェア Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023
出版日: 2018年12月21日 ページ情報: 英文 117 Pages
概要

世界の細胞治療技術の市場は予測期間中14.4%のCAGR (年間複合成長率) で推移し、2018年の102億米ドルから、2023年には199億米ドルの規模に成長すると予測されています。細胞関連の研究への国による投資の拡大、GMP認証を受けた製造施設の増加、多数の細胞ベースの癌治療薬の臨床試験の実施などの要因が同市場の成長を推進しています。しかし一方で、研究の高コスト性と低い成功率が同市場のさらなる成長の障壁となっています。

当レポートでは、世界の細胞治療技術の市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、製品・プロセス・細胞タイプ・エンドユーザー・地域別の動向と市場規模の推移と予測、競合環境、企業ランキング、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長抑制因子
    • 市場機会

第6章 細胞治療技術市場の分析・予測:製品別

  • イントロダクション
  • 消耗品
  • 機器
    • 細胞処理装置
    • 単回使用機器
    • その他
  • システム&ソフトウェア

第7章 細胞治療技術市場の分析・予測:プロセス別

  • イントロダクション
  • 細胞処理
  • 細胞保存・細胞分配・細胞操作
  • プロセスモニタリング・品質管理

第8章 細胞治療技術市場の分析・予測:細胞タイプ別

  • イントロダクション
  • ヒト細胞
    • 幹細胞
    • 分化細胞
  • 動物細胞

第9章 細胞治療技術市場の分析・予測:エンドユーザー別

  • イントロダクション
  • ライスサイエンス研究企業
  • 研究機関

第10章 細胞治療技術市場の分析・予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • その他
  • その他の地域

第11章 競合環境

  • 概要
  • 企業ランキング
  • 競合シナリオ

第12章 企業プロファイル

  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • TERUMO BCT, INC.
  • LONZA GROUP
  • GE HEALTHCARE
  • SARTORIUS
  • BECTON, DICKINSON AND COMPANY
  • BECKMAN COULTER, INC.
  • MILTENYI BIOTEC GMBH
  • STEMCELL TECHNOLOGIES

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: NATIONAL INSTITUTES OF HEALTH (NIH) FUNDING IN THE US, 2013-2016 (USD MILLION)
  • TABLE 2: BREAKDOWN OF CURRENT ACTIVE CELL THERAPY CLINICAL TRIALS BY CELL GROUP AND TRIAL PHASE
  • TABLE 3: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 4: CELL THERAPY CONSUMABLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: CELL THERAPY EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 7: CELL PROCESSING EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: SINGLE-USE EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: CELL THERAPY MARKET FOR OTHER EQUIPMENT, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 12: CELL THERAPY INSTRUMENTS MARKET FOR CELL PROCESSING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: CELL THERAPY INSTRUMENTS MARKET FOR CELL PRESERVATION, DISTRIBUTION, AND HANDLING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: CELL THERAPY INSTRUMENTS MARKET FOR PROCESS MONITORING AND QUALITY CONTROL, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 16: CELL THERAPY INSTRUMENTS MARKET FOR HUMAN CELLS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: CELL THERAPY INSTRUMENTS MARKET FOR HUMAN CELLS, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 18: CELL THERAPY INSTRUMENTS MARKET FOR STEM CELLS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: CELL THERAPY INSTRUMENTS MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: CELL THERAPY INSTRUMENTS MARKET FOR ANIMAL CELLS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 22: CELL THERAPY INSTRUMENTS MARKET FOR LIFE SCIENCE RESEARCH COMPANIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: CELL THERAPY INSTRUMENTS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: CELL THERAPY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 30: US: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 31: US: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 32: US: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 33: US: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 34: CANADA: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 35: CANADA: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 36: CANADA: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: CANADA: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 38: EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 39: EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 40: EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 41: EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 43: GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 44: GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 45: GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 46: GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 47: UK: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 48: UK: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 49: UK: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 50: UK: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 51: ROE: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 52: ROE: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 53: ROE: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 54: ROE: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 56: ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 57: ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 58: ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 59: ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 60: CHINA: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 61: CHINA: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 62: CHINA: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: CHINA: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 64: JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 65: JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 66: JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 67: JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 68: ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 69: ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 70: ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 72: ROW: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 73: ROW: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016-2023 (USD MILLION)
  • TABLE 74: ROW: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: ROW: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: CELL THERAPY INSTRUMENTS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: CELL THERAPY INSTRUMENTS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: CELL THERAPY INSTRUMENTS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: CELL THERAPY INSTRUMENTS MARKET, BY REGION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: RISING GOVERNMENT INVESTMENT FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: CONSUMABLES AND HUMAN CELLS TO DOMINATE THE CELL THERAPY INSTRUMENTS MARKET IN 2018
  • FIGURE 13: COUNTRIES IN ASIA TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: CELL THERAPY INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 15: CELL THERAPY CONSUMABLES TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 16: CELL PROCESSING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: HUMAN CELLS TO WITNESS THE HIGHEST GROWTH IN THE CELL THERAPY INSTRUMENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: LIFE SCIENCE RESEARCH COMPANIES TO BE THE LARGEST END-USER SEGMENT IN THE CELL THERAPY INSTRUMENTS MARKET
  • FIGURE 19: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE CELL THERAPY INSTRUMENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET SNAPSHOT
  • FIGURE 21: ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET SNAPSHOT
  • FIGURE 22: KEY DEVELOPMENTS IN THE CELL THERAPY INSTRUMENTS MARKET FROM 2015 TO 2018
  • FIGURE 23: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 24: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 25: TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 26: LONZA GROUP: COMPANY SNAPSHOT
  • FIGURE 27: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 28: SARTORIUS: COMPANY SNAPSHOT
  • FIGURE 29: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 30: DANAHER CORPORATION: COMPANY SNAPSHOT
目次
Product Code: BT 6823

"Global cell therapy instruments market to register a CAGR of 14.4% from 2018 to 2023"

The global cell therapy instruments market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period. Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market. However, the high cost of cell-based research and low success rate are expected to restrain market growth during the forecast period.

"Consumables segment to account for the largest market share in 2018"

Based on the product, the cell therapy instruments market is segmented into consumables, equipment, and systems & software. In 2018, the consumables segment is expected to account for the largest share of the cell therapy instruments market. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

"Cell processing segment dominates the cell therapy instruments market during the forecast period"

Based on process, the cell therapy instruments market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest share of the market in 2018 and is expected to grow at the highest CAGR during the forecasted period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.

"Human cells to register the highest growth during the forecast period"

Based on cell type, the cell therapy instruments market is segmented into human cells and animal cells. In 2018, the human cells segment is expected to account for the largest share of the cell therapy instruments market. The rising adoption of human cells over animal cells for cell therapeutics research, technological advancements, and the rising incidence of diseases such as cancer and cardiac abnormalities are the key factors driving the growth of this segment.

"North America to command the largest share of the cell therapy instruments market in 2018"

The cell therapy instruments market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest market share in 2018. The increasing R&D activities in the pharmaceutical and biotechnology industries is one of the major factors driving the demand for cell therapy instruments in North America during the forecast period.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, Director-level - 20%, and Others - 50%
  • By Region: North America - 35%, Europe - 24%, Asia Pacific - 25%, and the RoW - 16%

Major players in this market include: Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

Research Coverage:

This report studies the cell therapy instruments market based on product, cells type, process, end user, and region. The report also analyzes factors (such as drivers, opportunities, and restraints) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell therapy instruments market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on cell therapy instruments offered by the top 10 players in the global cell therapy instruments market. The report analyzes the cell therapy instruments market by product, cell type, end user, process stage, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell therapy instruments across key regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global cell therapy instruments market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the global cell therapy instruments market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL THERAPY INSTRUMENTS: MARKET OVERVIEW
  • 4.2. CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT & CELL TYPES (2018)
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE CELL THERAPY INSTRUMENTS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising government investments in cell-based research
      • 5.2.1.2. Large number of oncology-oriented cell-based therapy clinical trials
      • 5.2.1.3. Affordability and sustainability of advanced cell therapy instruments
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of cell-based research and low success rate
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging countries

6. CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. CONSUMABLES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL THERAPY INSTRUMENTS MARKET DURING THE FORECAST PERIOD
  • 6.3. EQUIPMENT
    • 6.3.1. CELL PROCESSING EQUIPMENT
      • 6.3.1.1. Cell processing equipment are essential in laboratories and institutes for conducting research
    • 6.3.2. SINGLE-USE EQUIPMENT
      • 6.3.2.1. Technological advancements & the increasing demand for biological products to drive market growth
    • 6.3.3. OTHER EQUIPMENT
  • 6.4. SYSTEMS & SOFTWARE
    • 6.4.1. CELL THERAPY SYSTEMS & SOFTWARE ARE USED TO MONITOR THE DIFFERENT STAGES OF CELL PROCESSING

7. CELL THERAPY INSTRUMENTS MARKET, BY PROCESS

  • 7.1. INTRODUCTION
  • 7.2. CELL PROCESSING
    • 7.2.1. CELL PROCESSING MAKES THE HIGHEST USE OF CELL THERAPY INSTRUMENTS, WHICH IS A MAJOR GROWTH DRIVER OF THIS SEGMENT
  • 7.3. CELL PRESERVATION, DISTRIBUTION, AND HANDLING
    • 7.3.1. DEMAND GROWTH FOR CELL-BASED MEDICAL PRODUCTS AND THERAPIES TO DRIVE THE MARKET FOR RELIABLE STORAGE EQUIPMENT
  • 7.4. PROCESS MONITORING AND QUALITY CONTROL
    • 7.4.1. PROCESS MONITORING IS ESSENTIAL TO ENSURE THE QUALITY AND ACCURACY OF CELL PROCESSING

8. CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE

  • 8.1. INTRODUCTION
  • 8.2. HUMAN CELLS
    • 8.2.1. STEM CELLS
      • 8.2.1.1. Investments from venture capitalists for stem cell research are a major factor driving the growth of this market
    • 8.2.2. DIFFERENTIATED CELLS
      • 8.2.2.1. Increasing investments from market players to develop new and innovative products is a key factor driving market growth
  • 8.3. ANIMAL CELLS
    • 8.3.1. GROWING INVESTMENTS IN ANIMAL CELL RESEARCH IS A MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET

9. CELL THERAPY INSTRUMENTS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. LIFE SCIENCE RESEARCH COMPANIES
    • 9.2.1. INCREASING NUMBER OF CELL-BASED EXPERIMENTS AND DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH
  • 9.3. RESEARCH INSTITUTES
    • 9.3.1. GROWING RESEARCH ACTIVITIES SUPPORTING THE GROWTH OF THIS END-USER SEGMENT

10. CELL THERAPY INSTRUMENTS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. US will continue to dominate the North American cell therapy instruments market during the forecast period
    • 10.2.2. CANADA
      • 10.2.2.1. High burden of chronic diseases to drive the adoption of cell therapy instruments in Canada
  • 10.3. EUROPE
    • 10.3.1. GERMANY
      • 10.3.1.1. Germany to be the fastest-growing market for cell therapy instruments in Europe
    • 10.3.2. UK
      • 10.3.2.1. Rising prevalence of NCDs in the UK to drive market growth
    • 10.3.3. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
      • 10.4.1.1. Increasing cell therapy-based research to support market growth in China
    • 10.4.2. JAPAN
      • 10.4.2.1. Increasing geriatric population and subsequent growth in the disease burden to support market growth in Japan
    • 10.4.3. REST OF ASIA PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET PLAYERS RANKING ANALYSIS, 2017
    • 11.2.1. TOP PLAYERS IN THE CELL THERAPY INSTRUMENTS MARKET
  • 11.3. COMPETITIVE SCENARIO

12. COMPANY PROFILES (Business overview, Products offered, Recent developments & MnM View)*

  • 12.1. THERMO FISHER SCIENTIFIC, INC.
  • 12.2. MERCK KGAA
  • 12.3. TERUMO BCT, INC. (A SUBSIDIARY OF TERUMO CORPORATION)
  • 12.4. LONZA GROUP
  • 12.5. GE HEALTHCARE
  • 12.6. SARTORIUS
  • 12.7. BECTON, DICKINSON AND COMPANY
  • 12.8. BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION)
  • 12.9. MILTENYI BIOTEC GMBH
  • 12.10. STEMCELL TECHNOLOGIES

*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS
Back to Top